Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
about
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heartFibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular developmentHigh-glucose inhibits human fibroblast cell migration in wound healing via repression of bFGF-regulating JNK phosphorylationMacrophages in collateral arteriogenesis.Cardiomyocyte FGF signaling is required for Cx43 phosphorylation and cardiac gap junction maintenance.Cardiovascular risk factors among women with self-reported infertilityImproved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model.Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis.AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet.Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.Protein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction.Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion modelFibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damageFibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycinFibroblast growth factor 2 is an essential cardioprotective factor in a closed-chest model of cardiac ischemia-reperfusion injuryFibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodelingThe cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signalingHydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis.Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).PI3K/Akt/FoxO3a signaling mediates cardioprotection of FGF-2 against hydrogen peroxide-induced apoptosis in H9c2 cells.Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2.Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular functionEndothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injuryRebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization.Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.Gene targeted ablation of high molecular weight fibroblast growth factor-2.Endothelial cells in allograft rejectionBiological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature.Cardioprotective growth factors.Hibernating myocardium: pathophysiology, diagnosis, and treatment.Inhibition of CD34+ cell migration by matrix metalloproteinase-2 during acute myocardial ischemia, counteracted by ischemic preconditioningRegulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generationCommon threads in cardiac fibrosis, infarct scar formation, and wound healing.Biomimetic materials and scaffolds for myocardial tissue regeneration.Fibroblast growth factor 2 protects against renal ischaemia/reperfusion injury by attenuating mitochondrial damage and proinflammatory signalling.Cardiac actions of fibroblast growth factor 23.A Novel Technique for Accelerated Culture of Murine Mesenchymal Stem Cells that Allows for Sustained Multipotency.The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
P2860
Q28509556-D9A96FB5-3D9B-4C34-ABE8-BA64BFA60006Q28511544-DC57A691-F9CD-4FF5-81A1-16B17E1A3178Q28543141-5756C44B-2538-44FD-8569-6E12A9846A5EQ30525251-45772883-BD42-45D1-B1E6-9AADDAF2C08BQ30546913-F6EB1750-167E-44F9-BB57-EAAF8702FD27Q33655058-38D283E2-F8DE-4900-BBB8-7D6236D31118Q33759629-7D86DCBF-657F-4106-9FF8-633C2B10CE61Q34218313-73CCBF2D-E3A4-4696-B64D-DEFA659BB1ADQ34306694-8D10FF90-564C-46B6-B73F-248AA5C217CDQ34517887-1A5367B5-47EA-409C-BDFB-1D9BA2CEBEC6Q34639920-EE2A088B-6520-4B20-B4D6-4BACE10A17B0Q34982162-813D77AA-F0ED-4757-8AC5-6F62F4B91185Q35020888-72B77FD1-0CBD-4713-A55F-B41962A05594Q35070159-4EC8AF7A-6A3B-477E-9B65-ECF168168D44Q35207699-9AB5238B-4024-4803-B422-1AAC6DBA9AFDQ35294164-4CA341AE-8986-427D-9A64-DE3B9ED65539Q35627274-286E223E-F387-4043-801F-81A8E4EB9E44Q35751876-D4818427-529E-4963-8FDC-8698346FE21AQ35828530-5A73B242-38A8-4338-99BD-434AFFC4589DQ35902490-AF6C52F2-1922-42E3-A17E-6B63D0C1C558Q35930071-BF446B80-3765-414C-B459-1EBD51AB3EFDQ36006513-27FA636C-F113-4698-B03B-65D915E807EEQ36095572-046407D1-9523-490B-A0D4-DE58FAA80F14Q36699574-AB9C3307-8BE0-472B-A32F-B02C514B8005Q36785331-7D072FBE-6B95-4C50-9A8F-FC899F2AA500Q36837898-AB4DDB94-87FE-459E-A5D6-790BDFEF4642Q37113792-1B33E09C-2490-4425-945F-0F7B69DAFF5DQ37135746-C2B265C8-EB65-4B74-B394-B2B778C713D2Q37261502-9872F066-B629-4669-8DDC-091831E796B5Q37380465-D41E1031-3D15-41E8-AF24-849696506DF6Q37393585-ECDE5C57-3DC6-4F2F-8B16-621C2DF94D56Q37445512-79668B57-78DC-43BC-B117-B9C6688D5144Q37659174-E43F84C5-D682-486B-8741-31A0D80E197AQ37676060-CE1D42FD-0F70-45D5-BB30-0E2E1CCA3A64Q38056814-AFDB87CD-D514-4DDB-BF0D-0B3CCDAA8036Q38120233-54E6732C-AF3A-4768-968D-A65EA489B8FFQ38763973-3887815F-2C13-49CE-9980-8272D08E4EEAQ38977291-7B1D3715-3622-4222-BB24-09DBD4CFC18DQ42656999-387B79EC-6C0B-4F99-9E31-33A1F26D27EFQ42864382-5A49BE92-92FD-42E4-979E-17A5081A3FFD
P2860
Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@ast
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@en
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@nl
type
label
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@ast
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@en
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@nl
prefLabel
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@ast
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@en
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@nl
P2093
P1433
P1476
Cardiac-specific overexpressio ...... ne model of low-flow ischemia.
@en
P2093
Craig Bolte
Gilbert Newman
Jo El J Schultz
Raisa Klevitsky
Stacey L House
Thomas Doetschman
P304
P356
10.1161/01.CIR.0000105723.91637.1C
P407
P577
2003-12-01T00:00:00Z